Marathon Patent Group Announces 2018 Fiscal Year End Financial Results

Loading...
Loading...

LAS VEGAS, March 25, 2019 (GLOBE NEWSWIRE) -- Marathon Patent Group, Inc. (NASDAQ:MARA) ("Marathon" or "Company"), today announced its operating results for the twelve months ended December 31, 2018, as published in its Annual Report on Form 10-K filed today with the Securities and Exchange Commission.

Operating Results for the Year Ended December 31, 2018

  • Total revenue increased 201% to $1.6 million for the year ended December 31, 2018 compared to $0.5 million for the year ended December 31, 2017.

  • Operating loss improved to $12.1 million (inclusive of non-cash expenses) for the year ended December 31, 2018 compared to an operating loss of $14.2 million (inclusive of non-cash expenses) for the year ended December 31, 2017.

  • GAAP net loss improved to $(0.60) per basic and diluted share for the year ended December 31, 2018 compared to $(4.80) the year ended December 31, 2017.

  • Net cash used in operating activities decreased from $10,808,483 in 2017 to $8,238,571 in 2018, a decrease of $2,569,912. The $8,238,571 cash loss also included a onetime charge of $2,150,000 for the Symantec settlement. Without this settlement, the cash used in operating activities would have been $6,088,571.

  • The Company had approximately $2.6 million of cash and cash equivalents as of December 31, 2018.

Merrick Okamoto, Chief Executive Officer, stated, "We're pleased to have shown financial improvement on a year over year basis. Looking forward, our Board of Directors continues to seek potential acquisition opportunities that we deem to offer the best opportunity for appreciation for our shareholders."

Investor Notice

Loading...
Loading...

Investing in our securities involves a high degree of risk. Before making an investment decision, you should carefully consider the risks, uncertainties and forward-looking statements described under "Risk Factors" in Item 1A of our most recent Annual Report on Form 10-K for the fiscal year ended December 31, 2018. If any of these risks were to occur, our business, financial condition or results of operations would likely suffer. In that event, the value of our securities could decline, and you could lose part or all of your investment. The risks and uncertainties we describe are not the only ones facing us. Additional risks not presently known to us or that we currently deem immaterial may also impair our business operations. In addition, our past financial performance may not be a reliable indicator of future performance, and historical trends should not be used to anticipate results in the future. See "Safe Harbor" below.

Forward-Looking Statements

Statements made in this press release include forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements can be identified by the use of words such as "may," "will," "plan," "should," "expect," "anticipate," "estimate," "continue," or comparable terminology. Such forward-looking statements are inherently subject to certain risks, trends and uncertainties, many of which the Company cannot predict with accuracy and some of which the Company might not even anticipate and involve factors that may cause actual results to differ materially from those projected or suggested. Readers are cautioned not to place undue reliance on these forward-looking statements and are advised to consider the factors listed above together with the additional factors under the heading "Risk Factors" in the Company's Annual Reports on Form 10-K, as may be supplemented or amended by the Company's Quarterly Reports on Form 10-Q. The Company assumes no obligation to update or supplement forward-looking statements that become untrue because of subsequent events, new information or otherwise.

CONTACT INFORMATION

Name: Jason Assad
Phone: 678-570-6791
Email: Jason@marathonpg.com

    
  December 31,   December 31,
  2018   2017 
    
ASSETS    
Current assets:   
Cash and cash equivalents$2,551,171  $14,948,529 
Accounts receivable - net of allowance for bad debt of $0 and $387,976 for December 31, 2018 and December 31, 2017, respectively -   6,826 
Prepaid expenses and other current assets 464,006   92,855 
Total current assets 3,015,177   15,048,210 
    
Other assets:   
Property and equipment, net of accumulated depreciation and impairment charges of $4,338,931 and $134,513 for December 31, 2018 and December 31, 2017, respectively 1,034,575   10,011 
Intangible assets, net of accumulated amortization of $65,245 for December 31, 2018 1,144,755   - 
Total other assets 2,179,330   10,011 
TOTAL ASSETS $5,194,507   $15,058,221  
    
LIABILITIES AND STOCKHOLDERS' EQUITY    
    
Current liabilities:   
Accounts payable and accrued expenses$1,235,444  $1,961,784 
Litigation liability -   2,150,000 
Warrant liability 39,083   1,794,396 
Convertible notes payable, net of discount of $2,290,028 for December 31, 2017 999,106   1,763,920 
Total current liabilities 2,273,633   7,670,100 
Total liabilities 2,273,633   7,670,100 
    
 Commitments and Contingencies    
    
Stockholders' Equity:   
Preferred stock, $0.0001 par value, 50,000,000 shares authorized, 0 and 5,513 issued and outstanding at December 31, 2018 and December 31, 2017, respectively -   1 
Common stock, $0.0001 par value; 200,000,000 shares authorized; 25,519,940 and 12,477,781 issued and outstanding at December 31, 2018 and December 31, 2017, respectively 2,552   1,248 
Additional paid-in capital 105,459,482   97,113,723 
Accumulated other comprehensive loss (450,719)  (450,734)
Accumulated deficit (102,090,441)  (89,276,117)
Total stockholders' equity 2,920,874   7,388,121 
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY  $5,194,507   $15,058,221  
    


    
  For the year ended
  December 31,
  2018   2017 
Revenues    
Cryptocurrency mining revenue$1,495,402  $- 
Other revenue 66,970   519,622 
Total revenues   1,562,372   519,622 
    
Operating costs and expenses    
Cost of revenue 3,351,758   3,470,847 
Impairment of mining equipment 2,222,688   - 
Compensation and related taxes 1,984,301   4,362,371 
Consulting fees 639,094   537,695 
Professional fees 1,216,820   2,797,648 
General and administrative 1,374,047   831,001 
Goodwill impairment -   228,401 
Patent impairment -   2,475,149 
Break-up fee -  issuance of shares to GBV 2,850,000   - 
Total operating expenses  13,638,708   14,703,112 
Operating loss  (12,076,336)  (14,183,490)
Other income (expenses)    
Other income (expenses) 112,471   (3,173,341)
Foreign exchange gain (loss) 28,918   (463,821)
Gain on debt extinguishment -   2,970,313 
Gain on Fortress debt settlement -   11,940,493 
Loss on sale of companies -   (2,610,783)
Realized loss on sale of digital currencies (152,485)  - 
Change in fair value adjustment of Clouding IP earn out -   1,482,012 
Change in fair value of warrant liability 1,699,522   (21,855,723)
Loss on warrants exchanged for common stock -   (980,400)
Gain on exchange of warrants to series E -   305,358 
Amortization of debt discount (2,290,028)  (3,561,109)
Interest income 14,230   2,793 
Interest expense (81,482)  (1,309,823)
Loss before income taxes  (12,745,190)  (31,437,521)
Income tax (expense) benefit (69,134)  103,952 
Net loss attributable to common stockholders $(12,814,324) $(31,333,569)
    
Net loss per share, basic and diluted: $(0.60) $(4.80)
Weighted average shares outstanding, basic and diluted:  21,263,774   6,522,649 
    
    
Net loss attributable to common stockholders $(12,814,324) $(31,333,569)
Other comprehensive income:   
Unrealized gain on foreign currency translation 15   609,656 
Comprehensive loss attributable to Marathon Patent Group, Inc. $(12,814,309) $(30,723,913)
    


                  
 Preferred Stock  Common Stock  Additional
Paid-in
Capital
 
 Accumulated
Deficit
 
  Accumulated
Other
Comprehensive
Income (Loss)
 
 Non-Controlling
Interest
 
 Total
Stockholders'
Equity
 
 Number  Amount  Number  Amount      
Balance as of December 31, 2016195,501   $20   4,638,118  $463  $49,879,161   $ (57,942,548) $(1,060,390) $(163,848) $(9,287,142)
Stock-based compensation expense  -      -     775,000    78    1,976,738     -      -      -      1,976,816 
Issuance of Series D Preferred Stock  125,688     13    -     -     678,700     -      -      -      678,713 
Conversion of Series B Preferred Stock  (195,500)    (20)   195,500    20    -      -      -      -      -  
Conversion of Series D Preferred Stock  (125,688)    (13)   628,438    63    107,224     -      -      -      107,274 
Warrants converted to Series E preferred stock  5,512     1    -    -     21,525,410     -      -      -      21,525,411 
Common stock issued for note conversion  -      -     1,807,565    181    1,445,871     -      -      -      1,446,052 
Beneficial conversion feature  -      -     -     -     4,017,729     -      -      -      4,017,729 
Proceeds received from private placement  -      -     3,492,047    349    16,074,067     -      -      -      16,074,416 
Issue common stock for conversion of warrants  -      -     619,250    62    1,183,966     -      -      -      1,184,028 
Warrant liability  -      -     -     -     137,334     -      -      -      137,334 
Common stock issued for account payable  -      -     320,449    32    435,457     -      -      -      435,489 
Loss on sale of companies  -      -     -     -     (42,576)    -      -      -      (42,576)
Gain on extinguishment of warrant liability  -      -     -     -     (305,358)    -      -      -      (305,358)
Par value adjustment and additional shares issued due to reverse split  -      -     1,414    -     -      -      -      -      -  
Currency translation loss  -      -     -     -     -      -      609,656     -      609,656 
Net loss  -      -     -     -     -      (31,333,569)    -      163,848     (31,169,721)
Balance as of December 31, 2017 5,513    1   12,477,781     1,248     97,113,723    (89,276,117)    (450,734) $   -       7,388,121  
Stock based compensation  -      -     443,400    44    1,425,639     -      -      -      1,425,683 
Conversion of Series E preferred stock(5,513)    (1)   5,511,543    551    (550)    -      -      -      -  
Common stock issued for acquisition of patents  -      -     250,000    25    959,975     -      -      -      960,000 
Issue common stock for exercise of warrants  -      -     17,731    2    55,789     -      -      -      55,791 
Common stock issuance related to note conversion  -      -     3,819,485    382    3,055,206     -      -      -      3,055,588 
Break-up fee -  issuance of shares to GBV  -      -     3,000,000    300    2,849,700     -      -        2,850,000 
Currency translation gain  -      -     -     -     -      -      15     -      15 
Net loss  -      -     -     -     -      (12,814,324)    -      -      (12,814,324)
Balance as of December 31, 2018 -    $ -    25,519,940  $2,552  $105,459,482   $(102,090,441) $(450,719) $ -    $2,920,874  
                  

 

    
  For the year ended
  December 31,
   2018     2017  
 CASH FLOWS FROM OPERATING ACTIVITIES    
 Net loss$  (12,814,324) $  (31,333,569)
 Adjustments to reconcile net loss to net cash (used in) operating activities:   
 Depreciation   2,003,695     26,106 
 Amortization of patents and website   66,017     1,824,162 
 Loss on sale of companies   -      2,610,784 
 Gain on debt extinguishment   -      (2,970,313)
 Gain on extinguishment of warrant liability    -      (305,358)
 Gain on Fortress loan extinguishment   -      (11,940,494)
 Realized loss on sale of digital currencies   152,485     -  
 Change in fair value of warrant liability   (1,699,522)    21,855,723 
 Impairment of intangible assets   -      2,475,149 
 Impairment of goodwill   -      228,401 
 Impairment of mining equipment   2,222,688     -  
 Stock based compensation   1,425,683     1,976,816 
 Amortization of debt discount   2,290,028     3,561,109 
 Warrants exchanged for common stock   -      980,400 
 Bad debt allowance   6,826     -  
 Change in fair value of Clouding earnout   -      (1,482,012)
 Break-up fee -  issuance of shares to GBV   2,850,000     -  
 Non-controlling interest   -      163,848 
 Litigation liability   -      2,150,000 
 Changes in operating assets and liabilities:   
 Accounts receivables   -      88,243 
 Digital currencies   (1,495,402)    -  
 Litigation liability   (2,150,000)    -  
 Prepaid expenses and other assets   (371,151)    335,194 
 Other non current assets   -      201,203 
 Accounts payable and accrued expenses   (725,594)    (1,253,875)
 Net cash used in operating activities   (8,238,571)    (10,808,483)
 CASH FLOWS FROM INVESTING ACTIVITIES    
 Purchase of digital currencies   1,342,917     -  
 Acquisition of patents   (250,000)    -  
 Purchase of property and equipment   (5,251,719)    (7,788)
 Net cash used in investing activities   (4,158,802)    (7,788)
 CASH FLOWS FROM FINANCING ACTIVITIES    
 Payment on note payable   -      (1,273,000)
 Proceeds received on issuance of notes payable   -      5,488,693 
 Proceeds received on private placement   -      16,074,416 
 Proceeds from warrant purchase   -      17,410 
 Proceeds received on exercise of warrants   -      141,100 
 Net cash provided by financing activities   -      20,448,619 
    
 Effect of foreign exchange rate changes   15     317,867 
    
 Net (decrease) increase  in cash and cash equivalents   (12,397,358)    9,950,215 
 Cash and cash equivalents — beginning of period   14,948,529     4,998,314 
 Cash and cash equivalents — end of period$  2,551,171  $  14,948,529 
    
 SUPPLEMENTAL CASH FLOW INFORMATION    
 Cash paid for interest expense$  -   $  1,543,925 
 Cash paid during the year for income taxes$  -   $  5,459 
    
 Supplemental schedule of non-cash investing and financing activities:    
 Issuance of Series D Preferred Stock$  -   $  678,713 
 Conversion of Series B Preferred Stock to common stock$  -   $  20 
 Conversion of Series D Preferred Stock to common stock$  -   $  63 
 Conversion of Series E Preferred Stock to common stock$  551  $  -  
 Warrants converted to Series E preferred stock$  -   $  21,525,410 
 Warrants reclassed to equity$  -   $  18,187 
 Common stock issued for acquisition of patents$  960,000  $  -  
 Common stock issued for note conversion$  3,055,588  $  1,549,803 
 Restricted stock issuance$  44  $  78 
 Beneficial conversion feature$  -   $  4,017,729 
 Common stock issued fro account payable$  -   $  331,739 
 Warrants exercised into common shares$  55,791  $  -  
    

 

Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: CryptocurrencyMarketsPress Releases
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...